Autophagy contributes to dasatinib-induced myeloid differentiation of human acute myeloid leukemia cells

Biochemical Pharmacology

Volumn 89, Issue 1, 2014, Pages 74-85

  Xie, Nan ^a   Zhong, Like ^a   Liu, Lu ^a   Fang, Yanfeng ^a   Qi, Xiaotian ^a   Cao, Ji ^a   Yang, Bo ^a   He, Qiaojun ^a   Ying, Meidan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; ATRA; Autophagy; Dasatinib; Differentiation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CHLOROQUINE; DASATINIB; RAPAMYCIN; RETINOIC ACID RECEPTOR ALPHA; WORTMANNIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACUTE MYELOID LEUKEMIA; ATRA; AUTOPHAGY; DASATINIB; DIFFERENTIATION;

ANDROSTADIENES; AUTOPHAGY; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHLOROQUINE; CHROMONES; DNA PRIMERS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MORPHOLINES; POLYMERASE CHAIN REACTION; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RECEPTORS, RETINOIC ACID; THIAZOLES; UP-REGULATION;

EID: 84897993782     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.02.019     Document Type: Article

References (40)

1. G. Marcucci, T. Haferlach, and H. Döhner Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications Journal of Clinical Oncology 29 2011 475 486
2. 3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia Proceedings of the National Academy of Sciences of the United States of America 101 2004 5328 5335 (Pubitemid 38481160)
3. A. Burnett, M. Wetzler, and B. Löwenberg Therapeutic advances in acute myeloid leukemia Journal of Clinical Oncology 29 2011 487 494
4. J. Congleton, R. MacDonald, and A. Yen Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells Leukemia 26 2011 1180 1188
5. P. Kropf, L. Wang, Y. Zang, R. Redner, and D. Johnson Dasatinib promotes ATRA-induced differentiation of AML cells Leukemia 24 2009 663 665
6. M.B. Miranda, R.L. Redner, and D.E. Johnson Inhibition of Src family kinases enhances retinoic acid-induced gene expression and myeloid differentiation Molecular Cancer Therapeutics 6 2007 3081 3090
7. G.E. Konecny, R. Glas, J. Dering, K. Manivong, J. Qi, and R.S. Finn et al. Activity of the multikinase inhibitor dasatinib against ovarian cancer cells British Journal of Cancer 101 2009 1699 1708
8. P. Shami, and M. Deininger Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR-ABL inhibitors as first-line therapy Leukemia 26 2011 214 224
9. S.A. Rosenzweig Acquired resistance to drugs targeting receptor tyrosine kinases Biochemical Pharmacology 83 2012 1041 1048
10. C. Drullion, V. Lagarde, R. Gioia, P. Legembre, M. Priault, and B. Cardinaud et al. Mycophenolic acid overcomes imatinib and nilotinib resistance of chronic myeloid leukemia cells by apoptosis or a senescent-like cell cycle arrest Leukemia Research and Treatment 2012 2012
11. G. Saglio, D.-W. Kim, S. Issaragrisil, P. Le Coutre, G. Etienne, and C. Lobo et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia New England Journal of Medicine 362 2010 2251 2259
12. H. Kantarjian, E. Jabbour, J. Grimley, and P. Dasatinib Kirkpatrick Nature Reviews Drug Discovery 5 2006 717 718
13. D.E. Johnson Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis Advances in Enzyme Regulation 48 2008 98
14. Y. Fang, L. Zhong, M. Lin, X. Zhou, H. Jing, and M. Ying et al. MEK/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acute myeloid leukemia PLoS One 8 2013 e66915
15. K. Porkka, P. Koskenvesa, T. Lundán, J. Rimpiläinen, S. Mustjoki, and R. Smykla et al. Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia Blood 112 2008 1005 1012
16. J. LoPiccolo, G.M. Blumenthal, W.B. Bernstein, and P.A. Dennis Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations Drug Resistance Updates 11 2008 32 50
17. Y.-T. Wu, H.-L. Tan, Q. Huang, C.-N. Ong, and H.-M. Shen Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy Autophagy 5 2009 824 834
18. N. Mizushima, and B. Levine Autophagy in mammalian development and differentiation Nature Cell Biology 12 2010 823 830
19. R. Singh, Y. Xiang, Y. Wang, K. Baikati, A.M. Cuervo, and Y.K. Luu et al. Autophagy regulates adipose mass and differentiation in mice Journal of Clinical Investigation 119 2009 3329
20. Z. Wang, L. Cao, R. Kang, M. Yang, L. Liu, and Y. Zhao et al. Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARα oncoprotein Autophagy 7 2011 401
21. M. Ying, X. Zhou, L. Zhong, N. Lin, H. Jing, and P. Luo et al. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARalpha/STAT1 axis Molecular Cancer Therapeutics 12 2013 195 206
22. G.I. Evan, and K.H. Vousden Proliferation, cell cycle and apoptosis in cancer Nature 411 2001 342 348 (Pubitemid 32467043)
23. P. Luo, X. Yang, M. Ying, P. Chaudhry, A. Wang, and H. Shimada et al. Retinoid-suppressed phosphorylation of RARalpha mediates the differentiation pathway of osteosarcoma cells Oncogene 29 2010 2772 2783
24. A. Kakizuka, W. Miller Jr., K. Umesono, R. Warrell Jr., S. Frankel, and V. Murty et al. Chromosomal translocation t (15; 17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML Cell 66 1991 663 674 (Pubitemid 121001702)
25. S.J. Collins, K.A. Robertson, and L. Mueller Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha) Molecular and Cellular Biology 10 1990 2154 2163
26. V. Milano, Y. Piao, T. LaFortune, and J. de Groot Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma Molecular Cancer Therapeutics 8 2009 394 406
27. E. Lainey, S. Thépot, C. Bouteloup, M. Sébert, L. Adès, and M. Tailler et al. Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of action Biochemical Pharmacology 82 2011 1457 1466
28. N. Chevalier, M. Solari, H. Becker, M. Pantic, F. Gärtner, and A. Maul-Pavicic et al. Robust in vivo differentiation of t (8; 21)-positive acute myeloid leukemia blasts to neutrophilic granulocytes induced by treatment with dasatinib Leukemia 24 2010 1779 1781
29. Y. Kabeya, N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, and T. Noda et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing EMBO Journal 19 2000 5720 5728
30. N. Mizushima, and T. Yoshimori How to interpret LC3 immunoblotting Autophagy 3 2007 542 545 (Pubitemid 350060049)
31. A. Biederbick, H.F. Kern, and H.P. Elsasser Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles European Journal of Cell Biology 66 1995 3 14
32. J. Kim, and D.J. Klionsky Autophagy, cytoplasm-to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells Annual Review of Biochemistry 69 2000 303 342
33. M. Degtyarev, A. De Maziere, C. Orr, J. Lin, B.B. Lee, and J.Y. Tien et al. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents Journal of Cell Biology 183 2008 101 116
34. B. Ravikumar, C. Vacher, Z. Berger, J.E. Davies, S. Luo, and L.G. Oroz et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease Nature Genetics 36 2004 585 595 (Pubitemid 38715985)
35. F. Huang, K. Reeves, X. Han, C. Fairchild, S. Platero, and T.W. Wong et al. Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection Cancer Research 67 2007 2226 2238 (Pubitemid 46424242)
36. E.K. Greuber, P. Smith-Pearson, J. Wang, and A.M. Pendergast Role of ABL family kinases in cancer: from leukaemia to solid tumours Nature Reviews Cancer 13 2013 559 571
37. F. Cecconi, and B. Levine The role of autophagy in mammalian development: cell makeover rather than cell death Developmental Cell 15 2008 344 357
38. C. Drullion, C. Trégoat, V. Lagarde, S. Tan, R. Gioia, and M. Priault et al. Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence Cell Death & Disease 3 2012 e373
39. P. Colosetti, A. Puissant, G. Robert, F. Luciano, A. Jacquel, and P. Gounon et al. Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line Autophagy 5 2009 1092 1098
40. Isakson P. Bjoras M. Boe S.O. Simonsen A., Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein, Blood, 2010, 116, 2324-2331.